TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2337211

Group type: EXPERIMENTAL
Intervention: Epidural fentanyl (100 micrograms)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (2 ml saline with 0.5% bupivacaine)
Number of subjects: 30
Study: 204183

Group type: EXPERIMENTAL
Intervention: Group A: diet for 6 weeks, then diet plus clofibrate for 18 weeks
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Group B: diet treatment from a clinic nutritionist with cooperation of the subject's private physician
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Group C: referral for treatment by a private physician
Number of subjects: 146

Group type: COMPARATOR
Intervention: Group D: no intervention
Number of subjects: 146
Study: 30870054

Group type: EXPERIMENTAL
Intervention: No heavy drinking days (NHDD)
Number of subjects: 888

Group type: EXPERIMENTAL
Intervention: Percent heavy drinking days (PHDD)
Number of subjects: 888

Group type: EXPERIMENTAL
Intervention: Drink size misestimation
Number of subjects: 888
Study: 28032908

Group type: EXPERIMENTAL
Intervention: Probiotics (Lactobacillus plantarum and Lactobacillus brevis)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo preparation
Number of subjects: 20
Study: 25458662

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (exercise training, multidisciplinary care through a nurse practitioner‐led CKD clinic)
Number of subjects: 83
Study: 23596811

Group type: EXPERIMENTAL
Intervention: Scalp electroacupuncture
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: Syndrome differentiation
Number of subjects: 233

Group type: COMPARATOR
Intervention: Nimodipine (drug group)
Number of subjects: 233
Study: 21550374

Group type: EXPERIMENTAL
Intervention: 23-valent pneumococcal polysaccharide vaccine (PPV), Haemophilus influenzae type b conjugate vaccine, and tetanus toxoid
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PPV at 7 or 17 weeks and second dose at 3 years of age
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Maternal vaccination
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PPV revaccination at 3 years of age
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tetanus toxoid alone
Number of subjects: 0
Study: 19765879

Group type: EXPERIMENTAL
Intervention: Diaphragm use for HIV prevention
Number of subjects: 2316

Group type: EXPERIMENTAL
Intervention: Covert use of diaphragm
Number of subjects: 2316

Group type: EXPERIMENTAL
Intervention: Qualitative analysis of disclosure levels
Number of subjects: 2316
Study: 16360855

Group type: EXPERIMENTAL
Intervention: 2‐mm self‐reinforced polylactate (PLLDL 70/30) biodegradable screws (group B)
Number of subjects: 69

Group type: COMPARATOR
Intervention: 2‐mm titanium screws (group T)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Comparison of stability between groups
Number of subjects: 69
Study: 15624548

Group type: EXPERIMENTAL
Intervention: Fluoxetine 40 mg/day
Number of subjects: 22
Study: 11768322

Group type: EXPERIMENTAL
Intervention: 300 mg/day alpha-tocopherol for 14 days
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 4g of ascorbic acid administered intravenously prior to induction
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 4g of ascorbic acid administered in the cardioplegic solution
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 48
Study: 9236545

Group type: EXPERIMENTAL
Intervention: Families of affectively ill juveniles
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Mothers of affectively ill youths
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Relatives of affectively ill probands
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Familial illness patterns
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Families of depressed youngsters
Number of subjects: 180
Study: 8175843

Group type: EXPERIMENTAL
Intervention: Cemented Hastings hemiarthroplasty
Number of subjects: 20

Group type: COMPARATOR
Intervention: Uncemented Austin‐Moore hemiarthroplasty
Number of subjects: 20
Study: 3148470

Group type: EXPERIMENTAL
Intervention: Ketorolac 10 mg i.m.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ketorolac 90 mg i.m.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Morphine 10 mg i.m.
Number of subjects: 0
Study: 29301824

Group type: EXPERIMENTAL
Intervention: ITCA 650 (20 μg/day for 13 weeks, then 60 μg/day for 26 weeks)
Number of subjects: 60
Study: 27000103

Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 166
Study: 25895497

Group type: EXPERIMENTAL
Intervention: Desmopressin 0.3 μg/kg
Number of subjects: 90

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 90
Study: 22638548

Group type: EXPERIMENTAL
Intervention: HbA1c increase by 1 percentage point
Number of subjects: 8252

Group type: COMPARATOR
Intervention: HbA1c ≤ 6.4% (≤ 46 mmol/l)
Number of subjects: 8252
Study: 21831757

Group type: COMPARATOR
Intervention: Raffinose diet
Number of subjects: 12

Group type: COMPARATOR
Intervention: Chickpea diet
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Control diet
Number of subjects: 12
Study: 18261561

Group type: EXPERIMENTAL
Intervention: Sirolimus (SRL)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Cyclosporine (CNI)
Number of subjects: 20
Study: 16185966

Group type: EXPERIMENTAL
Intervention: Cirrhosis and portal hypertension patients (n=37)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control patients (n=34)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Comparison of patients with and without PHE
Number of subjects: 37
Study: 12933387

Group type: EXPERIMENTAL
Intervention: N(2)O/air
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: air/N(2)O
Number of subjects: 10

Group type: COMPARATOR
Intervention: propofol anesthesia
Number of subjects: 10
Study: 10684784

Group type: EXPERIMENTAL
Intervention: Naltrexone 50 mg
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Carbamazepine 600-800 mg
Number of subjects: 160

Group type: COMPARATOR
Intervention: Naltrexone
Number of subjects: 160
Study: 8788104

Group type: EXPERIMENTAL
Intervention: Microvel
Number of subjects: 80

Group type: COMPARATOR
Intervention: Vasculour‐II
Number of subjects: 80
Study: 1290731

Group type: EXPERIMENTAL
Intervention: Coronary bypass surgery
Number of subjects: 348

Group type: COMPARATOR
Intervention: Continuing medical treatment
Number of subjects: 348
Study: 6394209

Group type: EXPERIMENTAL
Intervention: Experimental treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 0
Study: 30738387

Group type: EXPERIMENTAL
Intervention: Presence of choroidal collaterals (collateral-positive group)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Absence of choroidal collaterals (collateral-negative group)
Number of subjects: 36
Study: 29782035

Group type: EXPERIMENTAL
Intervention: Fixed-dose combination tablet of rosuvastatin-ezetimibe
Number of subjects: 24

Group type: COMPARATOR
Intervention: Separate tablets of rosuvastatin and ezetimibe
Number of subjects: 24
Study: 27161611

Group type: EXPERIMENTAL
Intervention: Tocilizumab (single dose prior to coronary angiography)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 117
Study: 24442858

Group type: EXPERIMENTAL
Intervention: Antithymocyte globulin and cyclosporine A (CSA)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Matched sibling donor hematopoietic stem cell transplantation
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: CSA and growth factors
Number of subjects: 50
Study: 23106871

Group type: EXPERIMENTAL
Intervention: TL-pulsed DC-CIK cells immunotherapy
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Interferon (IFN)-α immunotherapy
Number of subjects: 137

Group type: COMPARATOR
Intervention: Control group (no postoperative adjuvant therapy)
Number of subjects: 137
Study: 19544816

Group type: EXPERIMENTAL
Intervention: Air abrasion with Al2O3 particles
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Er:YAG laser irradiation
Number of subjects: 240

Group type: COMPARATOR
Intervention: Untreated surfaces
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Metal Primer (Alloy Primer, Metal Primer II, Metaltite)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Air abrasion with Al2O3 particles and application of metal primers
Number of subjects: 240
Study: 17284626

Group type: EXPERIMENTAL
Intervention: GH plus GnRHa (n=17)
Number of subjects: 32
Study: 14755010

Group type: COMPARATOR
Intervention: 5‐FU/LV alone (arm A)
Number of subjects: 463

Group type: COMPARATOR
Intervention: Oxaliplatin alone (arm B)
Number of subjects: 463

Group type: EXPERIMENTAL
Intervention: Oxaliplatin plus 5‐FU/LV (arm C)
Number of subjects: 463
Study: 11216931

Group type: EXPERIMENTAL
Intervention: HIV-positive individuals
Number of subjects: 482

Group type: COMPARATOR
Intervention: HIV-negative individuals
Number of subjects: 482
Study: 9744142

Group type: EXPERIMENTAL
Intervention: Budesonide Turbohaler 400 micrograms once daily
Number of subjects: 167

Group type: COMPARATOR
Intervention: Budesonide Turbohaler 200 micrograms twice daily
Number of subjects: 167
Study: 7848948

Group type: EXPERIMENTAL
Intervention: Metoclopramide 20 mg intramuscularly before and after surgery
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (saline)
Number of subjects: 48
Study: 3139698

Group type: EXPERIMENTAL
Intervention: HCG
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Progesterone and oestradiol valerate
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: GnRH agonist and HMG
Number of subjects: 91

Group type: COMPARATOR
Intervention: Clomiphene citrate‐HMG
Number of subjects: 91
Study: 30297663

Group type: EXPERIMENTAL
Intervention: 1 g/day n-3 LCPUFA as HiDHA™ tuna oil
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: 0.35 g/day n-3 LCPUFA as HiDHA™ tuna oil
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: 0.7 g/day n-3 LCPUFA as HiDHA™ tuna oil
Number of subjects: 53

Group type: COMPARATOR
Intervention: 0 g/day n-3 LCPUFA (placebo - Sunola oil)
Number of subjects: 53
Study: 26507926

Group type: EXPERIMENTAL
Intervention: Topical eflornithine applied twice daily for 6 months
Number of subjects: 22

Group type: COMPARATOR
Intervention: No eflornithine treatment (control)
Number of subjects: 22
Study: 25546177

Group type: EXPERIMENTAL
Intervention: Sono-electro-magnetic therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo therapy
Number of subjects: 60
Study: 22382382

Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stent (SES)
Number of subjects: 226

Group type: COMPARATOR
Intervention: Paclitaxel-eluting stent (PES)
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Positive peri-stent vascular remodeling (PPVR)
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Early discontinuation of dual antiplatelet therapy (DAPT)
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Late acquired stent malapposition (LASM)
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Stent length
Number of subjects: 226
Study: 20842042

Group type: EXPERIMENTAL
Intervention: Lopinavir/ritonavir (LPV/r) with transdermal contraceptive patch (ethinyl estradiol and norelgestromin)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Lopinavir/ritonavir (LPV/r) with oral contraceptive pill (ethinyl estradiol and norethindrone)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Lopinavir/ritonavir (LPV/r) with transdermal contraceptive patch
Number of subjects: 32
Study: 18375093

Group type: EXPERIMENTAL
Intervention: succinylcholine 1mg/kg + ephedrine 70 microg/kg (Group I)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: rocuronium 0.6 mg/kg + ephedrine 70 microg/kg (Group II)
Number of subjects: 80

Group type: COMPARATOR
Intervention: succinylcholine 1mg/kg + 0.9% saline (Group III)
Number of subjects: 80

Group type: COMPARATOR
Intervention: rocuronium 0.6 mg/kg + 0.9% saline (Group IV)
Number of subjects: 80
Study: 16909301

Group type: EXPERIMENTAL
Intervention: Patellar tendon graft (PT tendon)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 4 strand hamstring graft
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Single hamstring plus extraarticular plasty
Number of subjects: 75

Group type: COMPARATOR
Intervention: Bone-patellar tendon graft
Number of subjects: 75

Group type: COMPARATOR
Intervention: Four-strand hamstring group
Number of subjects: 75
Study: 14670701

Group type: EXPERIMENTAL
Intervention: Compound stimuli with element heterogeneity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Compound stimuli with element homogeneity
Number of subjects: 0
Study: 10997878

Group type: EXPERIMENTAL
Intervention: ATRA
Number of subjects: 86

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 86
Study: 8667273

Group type: EXPERIMENTAL
Intervention: Fluoro Core
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: VariGlass VLC
Number of subjects: 54

Group type: COMPARATOR
Intervention: Miracle Mix
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Thermocycling
Number of subjects: 54
Study: 1730278

Group type: EXPERIMENTAL
Intervention: Combination chemotherapy MOCCA (vincristine, cyclophosphamide, lomustine, melphalan, methylprednisolone)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Combination chemotherapy MOCCA
Number of subjects: 80
Study: 6144625

Group type: EXPERIMENTAL
Intervention: Somatostatin (250 micrograms per hr after a bolus of 50 micrograms)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Vasopressin (0.4 units per min)
Number of subjects: 61
Study: 30328654

Group type: EXPERIMENTAL
Intervention: CRT-D (Cardiac Resynchronization Therapy with a defibrillator)
Number of subjects: 1106

Group type: COMPARATOR
Intervention: ICD (Implantable Cardioverter Defibrillator)
Number of subjects: 1106
Study: 29802791

Group type: EXPERIMENTAL
Intervention: Everolimus
Number of subjects: 279

Group type: EXPERIMENTAL
Intervention: Everolimus + reduced-dose calcineurin-inhibitor
Number of subjects: 279

Group type: COMPARATOR
Intervention: Control
Number of subjects: 279
Study: 26374849

Group type: EXPERIMENTAL
Intervention: Spironolactone
Number of subjects: 3444
Study: 24630536

Group type: EXPERIMENTAL
Intervention: RT‐ARD score (0‐8, 9‐23, 24‐45)
Number of subjects: 309
Study: 22052627

Group type: EXPERIMENTAL
Intervention: Conventional therapy plus low-level laser therapy (4 J/cm(2) at each point over a maximum of ten painful points for total 5 min duration)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Routine physiotherapy
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Conventional therapy plus low-level laser therapy
Number of subjects: 50
Study: 19864958

Group type: EXPERIMENTAL
Intervention: Perindopril and Indapamide (active treatment)
Number of subjects: 6105

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 6105
Study: 17920465

Group type: EXPERIMENTAL
Intervention: Image-free navigation (group A)
Number of subjects: 467

Group type: COMPARATOR
Intervention: Optimized conventional technique (group B)
Number of subjects: 467

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 467
Study: 16822136

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 12792664

Group type: EXPERIMENTAL
Intervention: n-3 PUFAs (850-882 mg EPA and DHA as concentrated ethylesters)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Corn oil (1 g)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: n-3 PUFAs with statins
Number of subjects: 300

Group type: COMPARATOR
Intervention: Corn oil with statins
Number of subjects: 300
Study: 10926918

Group type: EXPERIMENTAL
Intervention: Autologous hematopoietic stem cell transplantation
Number of subjects: 0
Study: 8773822

Group type: EXPERIMENTAL
Intervention: Nefazodone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Imipramine
Number of subjects: 0
Study: 1611115

Group type: EXPERIMENTAL
Intervention: Intron A at 10 MU/instillation
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Intron A at 10 MU and mitomycin C (MMC) at 20 mg/instillation
Number of subjects: 67

Group type: COMPARATOR
Intervention: Mitomycin C (MMC) at 20 mg/instillation
Number of subjects: 67
Study: 6377568

Group type: EXPERIMENTAL
Intervention: High-dose streptokinase (100,000 U/h)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Low-dose streptokinase (approx 10,000 U/h) with low-dose heparin
Number of subjects: 80
Study: 30409926

Group type: EXPERIMENTAL
Intervention: Sertaconazole 2% cream
Number of subjects: 66

Group type: COMPARATOR
Intervention: Amorolfine 0.25% cream
Number of subjects: 66

Group type: COMPARATOR
Intervention: Both treatments
Number of subjects: 66
Study: 29092994

Group type: EXPERIMENTAL
Intervention: Low-intensity pulsed ultrasound (LIPUS)
Number of subjects: 501
Study: 25090010

Group type: EXPERIMENTAL
Intervention: 2-hour psycho-education session combined with bi-weekly telephone support
Number of subjects: 51
Study: 23228403

Group type: EXPERIMENTAL
Intervention: Gaseous nitric oxide (20 ppm)
Number of subjects: 16
Study: 21419391

Group type: EXPERIMENTAL
Intervention: FRIENDS cognitive‐behavioral therapy (CBT) intervention
Number of subjects: 444

Group type: COMPARATOR
Intervention: Attention-control (story-reading)
Number of subjects: 444
Study: 18806645

Group type: EXPERIMENTAL
Intervention: Patient-centered care (PCC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 16849680

Group type: EXPERIMENTAL
Intervention: H. pylori treatment (amoxicillin and omeprazole for 2 weeks)
Number of subjects: 3365

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3365

Group type: EXPERIMENTAL
Intervention: Garlic supplement (aged garlic extract and steam-distilled garlic oil for 7.3 years)
Number of subjects: 3365

Group type: EXPERIMENTAL
Intervention: Vitamin supplement (vitamin C, vitamin E, and selenium for 7.3 years)
Number of subjects: 3365
Study: 15238367

Group type: EXPERIMENTAL
Intervention: American ginseng
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 11162751

Group type: EXPERIMENTAL
Intervention: Remacemide hydrochloride (1200 mg/day, q.i.d. regimen)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Remacemide hydrochloride (800 mg/day, b.i.d. regimen)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Remacemide hydrochloride (600 mg/day)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Remacemide hydrochloride (1200 mg/day)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Concomitant AEDs
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Neuropsychological tests
Number of subjects: 40
Study: 9112891

Group type: EXPERIMENTAL
Intervention: Insufflation pressure of 7.5 mmHg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Insufflation pressure of 15 mmHg
Number of subjects: 40
Study: 1546820

Group type: EXPERIMENTAL
Intervention: Ketotifen, 2 mg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Clemastine, 1 mg
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6

Group type: COMPARATOR
Intervention: Sodium cromoglycate, 10 mg
Number of subjects: 6
Study: 3935589

Group type: EXPERIMENTAL
Intervention: Prophylactic treatment by phenoxymethyl penicillin
Number of subjects: 108

Group type: COMPARATOR
Intervention: Short ampicillin course only on the occasion of an acute otitis media episode
Number of subjects: 108
Study: 29314581

Group type: EXPERIMENTAL
Intervention: Mentored video review (M)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Independent video review (I)
Number of subjects: 23
Study: 29977080

Group type: COMPARATOR
Intervention: Ibuprofen 800 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ibuprofen 400 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 0
Study: 27221800

Group type: EXPERIMENTAL
Intervention: Mentors with greater self-efficacy and more previous involvement with youth in their communities
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mentors' previous involvement with youth
Number of subjects: 0

Group type: COMPARATOR
Intervention: Elevated environmental stress
Number of subjects: 0

Group type: COMPARATOR
Intervention: Elevated rates of youth behavioral problems
Number of subjects: 0
Study: 23274578

Group type: EXPERIMENTAL
Intervention: 50 mg clopidogrel
Number of subjects: 200

Group type: COMPARATOR
Intervention: 75 mg clopidogrel
Number of subjects: 200
Study: 22921739

Group type: EXPERIMENTAL
Intervention: Exercise (15 min arm and shoulder exercise task)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Half-dose Pneumococcal vaccination with exercise
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Full-dose Pneumococcal vaccination with exercise
Number of subjects: 133

Group type: COMPARATOR
Intervention: Control (resting quietly)
Number of subjects: 133
Study: 20813994

Group type: EXPERIMENTAL
Intervention: Aneurysm coiling
Number of subjects: 413

Group type: COMPARATOR
Intervention: Aneurysm clipping
Number of subjects: 413
Study: 17534605

Group type: EXPERIMENTAL
Intervention: Epinastine
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 12

Group type: COMPARATOR
Intervention: Ketotifen
Number of subjects: 12
Study: 16293154

Group type: EXPERIMENTAL
Intervention: Ice massage
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 12145115

Group type: EXPERIMENTAL
Intervention: 0600 hours
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 1800 hours
Number of subjects: 14

Group type: COMPARATOR
Intervention: Exercise protocol
Number of subjects: 14

Group type: COMPARATOR
Intervention: Before exercise
Number of subjects: 14
Study: 10214169

Group type: EXPERIMENTAL
Intervention: Multisensory therapy
Number of subjects: 1
Study: 7891982

Group type: EXPERIMENTAL
Intervention: Patients with visual compromise (n = 51)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control eyes (20 age-matched control subjects)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Patients with unilateral lesions (n = 29)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control subjects (20 age-matched control subjects)
Number of subjects: 29
Study: 2121551

Group type: EXPERIMENTAL
Intervention: Protocol 2: daily GnRH‐a beginning in the midluteal phase, followed by 150 IU hMG after down regulation
Number of subjects: 114

Group type: COMPARATOR
Intervention: Protocol 1: 100 mg of clomiphene citrate on days 5 to 9, followed by 150 IU hMG beginning on day 9
Number of subjects: 114
Study: 649030

Group type: EXPERIMENTAL
Intervention: 10 mg domperidon t.i.d. for 4 weeks
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo for 4 weeks
Number of subjects: 48
Study: 30926276

Group type: EXPERIMENTAL
Intervention: Fibrin Sealant Grifols (FS Grifols)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Manual Compression (MC)
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Fibrin Sealant Grifols (FS Grifols) and Manual Compression (MC)
Number of subjects: 166